Indian manufacturers produce liquid injections, dry powder injections, lyophilized injections, pre-filled syringes, and critical care injectables.
Benefits include reduced investment, faster product launches, regulatory support, quality production, and scalable manufacturing capabilities.
Manufacturers should possess WHO-GMP, ISO, Schedule M, and other regulatory certifications ensuring product quality.
Liquid injections are ready-to-use formulations, while dry powder injections require reconstitution before administration.
Critical care injections include antibiotics, antifungals, anticoagulants, ICU medicines, and emergency treatment formulations.
Evaluate certifications, manufacturing capacity, quality standards, product portfolio, regulatory compliance, and market reputation.
India offers advanced facilities, skilled professionals, cost-effective production, and globally recognized pharmaceutical manufacturing standards.
Yes, many Indian manufacturers export injectable products to regulated and semi-regulated pharmaceutical markets worldwide.
It is a manufacturing facility complying with World Health Organization Good Manufacturing Practice quality standards.
The process includes product selection, agreement signing, manufacturing, packaging, quality testing, and final delivery.
Common documents include drug licenses, GST registration, product approvals, trademark details, and agreements.
Pre-filled syringes contain premeasured medication doses and are widely used in hospitals and clinics.
Consider certifications, infrastructure, quality control systems, production capacity, product range, and regulatory compliance.
Growing healthcare infrastructure, ICU requirements, chronic diseases, and emergency care needs drive demand.
Benefits include strong demand, recurring prescriptions, higher margins, and expanding healthcare market opportunities.
Contact the company, discuss requirements, complete documentation, and finalize manufacturing or franchise agreements.
Common products include Meropenem, Cefepime, Pantoprazole, Enoxaparin, Iron Sucrose, and Amikacin injections.
Schedule M specifies GMP requirements ensuring pharmaceutical products are consistently manufactured under quality standards.
Yes, Pace Biotech operates WHO-GMP-compliant facilities focused on manufacturing high-quality injectable pharmaceutical products.
Pace Biotech offers liquid injections, dry powder injections, lyophilized injections, pre-filled syringes, and third-party manufacturing.
